Home › Urothelial (Transitional Cell) Carcinoma › Arkansas
Urothelial (Transitional Cell) Carcinoma clinical trials in Arkansas
5 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in Arkansas.
Cities in Arkansas
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Highlands Oncology Group, PA, Fayetteville
- Highlands Oncology Group, PA, Rogers
- Highlands Oncology Group, PA, Springdale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07421700A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07218380A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- University of Arkansas for Medical Sciences, Arkansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06774131An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Hot Springs
- Research Site, Little Rock
- Research Site, Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07720284SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.